C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 58/100How is this calculated?

DEA Process Puts Cannabis Equities Back on Proof

The DEA rescheduling record is now a policy catalyst, but the equity read-through depends on cash conversion, balance-sheet discipline and operating execution—not headlines alone.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.